The US Food and Drug Administration has approved Allergan's supplemental biologics application (sBLA) for its BOTOX treatment for paediatric patients with upper limb spasticity.
24 June 2019 News
5 June 2019 News
Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved Emgality (galcanezumab-gnlm) for episodic cluster headache in adults.
29 May 2019 Analysis
Ocrevus was the first disease modifying drugs approved for primary progressive MS, as well as relapsed forms of MS. After an initial hiccup with UK health regulators, Roche lowered the...
29 May 2019 Comment
It is arguable that limited treatment options for a rare disease such as spinal muscular atrophy means that approved therapies could launch at an exceptionally high price point.
22 May 2019 Analysis
Dementia refers to a large group of diseases that affect the brain. The most common form is Alzheimer’s, making it, unsurprisingly, the main target of pharma R&D. As these treatments...
21 May 2019 News
US-based T3D Therapeutics has announced it has received a $9m grant over four years from the US National Institutes of Health (NIH)’s National Institute of Aging to support its Phase...
7 May 2019 whitepapers
Paracetamol suspension is used for the treatment of mild-to-moderate pain, including headaches, migraines, neuralgia, toothaches, sore throat and period pains.
7 May 2019 News
UK-headquartered Bicycle Therapeutics and venture capital fund Dementia Discovery Fund (DDF) have entered into a collaboration to use the former’s bicyclic peptide technology to identify new targets and development novel...